Constructionbegins onWuxiBiologics plant inDundalk

Construction of

WuXi Biologics new manufacturing facility has commenced on the Industrial

Development Authority’s (IDA) greenfield site in Mullaharlin, the company announced last week.

‘We are excited to witness the construction of WuXi Biologics’ first global site,’ commented Dr. Chris Chen, Chief Executive Officer of WuXi Biologics. ‘ The commencement of this new facility symbolizes the significant start of our global biomanufacturing network to make sure that biologics can be manufactured at the highest quality, providing a robust supply chain to benefit patients worldwide. With this new project, we can actively work with all local partners to build this state-of-the-art biomanufacturing facility as a showcase to the entire global biotech community.’

This will be the company’s first manufacturing facility outside of China and is supported by the IDA.

Described as a state-of-the-art ‘facility of the future’, it is designed to run both traditional fed-batch or perfusion process and continuous bioprocessing, a next generation manufacturing technology to be first implemented globally in this 26-hectare campus. When completed, a total capacity of 48,000L fed-batch and 6,000L perfusion will be installed, representing one of the world’s largest facility using single-use bioreactors.